Assessment and Translation of the Antibody-in-Lymphocyte Supernatant (ALS) Assay to Improve the Diagnosis of Enteric Fever in Two Controlled Human Infection Models and an Endemic Area of Nepal
Thomas C Darton, Claire Jones, Sabina Dongol, Merryn Voysey, Christoph J Blohmke, Rajendra Shrestha, Abhilasha Karkey, Mila Shakya, Amit Arjyal, Claire S Waddington, Malick Gibani, Michael J Carter, Buddha Basnyat, Stephen Baker, Andrew J Pollard, Thomas C Darton, Claire Jones, Sabina Dongol, Merryn Voysey, Christoph J Blohmke, Rajendra Shrestha, Abhilasha Karkey, Mila Shakya, Amit Arjyal, Claire S Waddington, Malick Gibani, Michael J Carter, Buddha Basnyat, Stephen Baker, Andrew J Pollard
Abstract
New diagnostic tests for enteric fever are urgently needed to assist with timely antimicrobial treatment of patients and to measure the efficacy of prevention measures such as vaccination. In a novel translational approach, here we use two recently developed controlled human infection models (CHIM) of enteric fever to evaluate an antibody-in-lymphocyte supernatant (ALS) assay, which can detect recent IgA antibody production by circulating B cells in ex vivo mononuclear cell culture. We calculated the discriminative ability of the ALS assay to distinguish diagnosed cases in the two CHIM studies in Oxford, prior to evaluating blood culture-confirmed diagnoses of patients presenting with fever to hospital in an endemic areas of Kathmandu, Nepal. Antibody responses to membrane preparations and lipopolysaccharide provided good sensitivity (>90%) for diagnosing systemic infection after oral challenge with Salmonella Typhi or S. Paratyphi A. Assay specificity was moderate (~60%) due to imperfect sensitivity of blood culture as the reference standard and likely unrecognized subclinical infection. These findings were augmented through the translation of the assay into the endemic setting in Nepal. Anti-MP IgA responses again exhibited good sensitivity (86%) but poor specificity (51%) for detecting blood culture-confirmed enteric fever cases (ROC AUC 0.79, 95%CI 0.70-0.88). Patients with anti-MP IgA ALS titers in the upper quartile exhibited a clinical syndrome synonymous with enteric fever. While better reference standards are need to assess enteric fever diagnostics, routine use of this ALS assay could be used to rule out infection and has the potential to double the laboratory detection rate of enteric fever in this setting over blood culture alone.
Keywords: Salmonella Paratyphi A; Salmonella Typhi; antibody-in-lymphocyte supernatant assay; bacteremia; diagnostic test; enteric fever; febrile illness; resource-limited settings.
Figures
References
- Adhikari A., Rauniyar R., Raut P. P., Manandhar K. D., Gupta B. P. (2015). Evaluation of sensitivity and specificity of ELISA against Widal test for typhoid diagnosis in endemic population of Kathmandu. BMC Infect. Dis. 15:523. 10.1186/s12879-015-1248-6
- Arjyal A., Basnyat B., Nhan H. T., Koirala S., Giri A., Joshi N., et al. . (2016). Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial. Lancet Infect. Dis. 16, 535–545. 10.1016/S1473-3099(15)00530-7
- Baker S., Favorov M., Dougan G. (2010). Searching for the elusive typhoid diagnostic. BMC Infect. Dis. 10:45. 10.1186/1471-2334-10-45
- Buckle G. C., Walker C. L., Black R. E. (2012). Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J. Glob. Health 2:10401. 10.7189/jogh.01.010401
- Carstensen B., Gurrin L., Ekstrom C., Figurski M. (2013). MethComp: Functions for Analysis of Agreement in Method Comparison Studies. R Package version 1.22. Available online at: (Accessed on August 08, 2016).
- Chang H. S., Sack D. A. (2001). Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes. Clin. Diagn. Lab. Immunol. 8, 482–488. 10.1128/CDLI.8.3.482-488.2001
- Chappuis F., Alirol E., d'Acremont V., Bottieau E., Yansouni C. P. (2013). Rapid diagnostic tests for non-malarial febrile illness in the tropics. Clin. Microbiol. Infect. 19, 422–431. 10.1111/1469-0691.12154
- Crump J. A., Sjolund-Karlsson M., Gordon M. A., Parry C. M. (2015). Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin. Microbiol. Rev. 28, 901–937. 10.1128/CMR.00002-15
- Darton T. C., Blohmke C. J., Pollard A. J. (2014). Typhoid epidemiology, diagnostics and the human challenge model. Curr. Opin. Gastroenterol. 30, 7–17. 10.1097/MOG.0000000000000021
- Dewan A. M., Corner R., Hashizume M., Ongee E. T. (2013). Typhoid fever and its association with environmental factors in the Dhaka Metropolitan Area of Bangladesh: a spatial and time-series approach. PLoS Negl. Trop. Dis. 7:e1998. 10.1371/journal.pntd.0001998
- Garcia-Gomez E., Gonzalez-Pedrajo B., Camacho-Arroyo I. (2013). Role of sex steroid hormones in bacterial-host interactions. Biomed. Res. Int. 2013:928290. 10.1155/2013/928290
- Giavarina D. (2015). Understanding Bland Altman analysis. Biochem. Med. (Zagreb) 25, 141–151. 10.11613/BM.2015.015
- Health Protection Agency (2013). Investigation of blood cultures (for organisms other than Mycobacterium species. UK Standards for Microbiological Investigations.
- Islam K., Sayeed M. A., Hossen E., Khanam F., Charles R. C., Andrews J., et al. . (2016). Comparison of the performance of the TPTest, Tubex, Typhidot and Widal immunodiagnostic assays and blood cultures in detecting patients with typhoid fever in Bangladesh, including using a Bayesian latent class modeling approach. PLoS Negl. Trop. Dis. 10:e0004558. 10.1371/journal.pntd.0004558
- Jiao J., Wang M. S., Yang X. G., Wang X. F. (2015). Evaluation of ALS assay of TB-SA for diagnosis of pulmonary tuberculosis. J. Immunoassay Immunochem. 36, 119–127. 10.1080/15321819.2014.908127
- Karkey A., Arjyal A., Anders K. L., Boni M. F., Dongol S., Koirala S., et al. . (2010). The burden and characteristics of enteric fever at a healthcare facility in a densely populated area of Kathmandu. PLoS ONE 5:e13988. 10.1371/journal.pone.0013988
- Karkey A., Jombart T., Walker A. W., Thompson C. N., Torres A., Dongol S., et al. . (2016). The ecological dynamics of fecal contamination and Salmonella typhi and Salmonella paratyphi A in municipal Kathmandu drinking water. PLoS Negl. Trop. Dis. 10:e0004346. 10.1371/journal.pntd.0004346
- Karkey A., Thompson C. N., Tran Vu Thieu N., Dongol S., Le Thi Phuong T., Voong Vinh P., et al. . (2013). Differential epidemiology of Salmonella typhi and paratyphi A in Kathmandu, Nepal: a matched case control investigation in a highly endemic enteric fever setting. PLoS Negl. Trop. Dis. 7:e2391. 10.1371/journal.pntd.0002391
- Keddy K. H., Sooka A., Letsoalo M. E., Hoyland G., Chaignat C. L., Morrissey A. B., et al. . (2011). Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites. Bull. World Health Organ. 89, 640–647. 10.2471/BLT.11.087627
- Khanam F., Sheikh A., Sayeed A., Bhuiyan S., Choudhury F. K., Salma U., et al. . (2013). Evaluation of a typhoid/paratyphoid diagnostic assay (TPTest) detecting anti-Salmonella IgA in secretions of peripheral blood lymphocytes in patients in Dhaka, Bangladesh. PLoS Negl. Trop. Dis. 7:e2316. 10.1371/journal.pntd.0002316
- Kirkpatrick B. D., Bentley M. D., Thern A. M., Larsson C. J., Ventrone C., Sreenivasan M. V., et al. . (2005). Comparison of the antibodies in lymphocyte supernatant and antibody-secreting cell assays for measuring intestinal mucosal immune response to a novel oral typhoid vaccine (M01ZH09). Clin. Diagn. Lab. Immunol. 12, 1127–1129. 10.1128/CDLI.12.9.1127-1129.2005
- McCullagh D., Dobinson H. C., Darton T., Campbell D., Jones C., Snape M., et al. . (2015). Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers. BMJ Open 5:e007481. 10.1136/bmjopen-2014-007481
- Metz C. E. (1978). Basic principles of ROC analysis. Semin. Nucl. Med. 8, 283–298. 10.1016/S0001-2998(78)80014-2
- Parry C. M., Wijedoru L., Arjyal A., Baker S. (2011). The utility of diagnostic tests for enteric fever in endemic locations. Expert Rev. Anti. Infect. Ther. 9, 711–725. 10.1586/eri.11.47
- Robin X., Turck N., Hainard A., Tiberti N., Lisacek F., Sanchez J.-C., et al. . (2011). pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77. 10.1186/1471-2105-12-77
- Sheikh A., Bhuiyan M. S., Khanam F., Chowdhury F., Saha A., Ahmed D., et al. . (2009). Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid fever. Clin. Vaccine Immunol. 16, 1587–1594. 10.1128/CVI.00311-09
- Storey H. L., Huang Y., Crudder C., Golden A., de los Santos T., Hawkins K. (2015). A meta-analysis of typhoid diagnostic accuracy studies: a recommendation to adopt a standardized composite reference. PLoS ONE 10:e0142364. 10.1371/journal.pone.0142364
- Thompson C. N., Blacksell S. D., Paris D. H., Arjyal A., Karkey A., Dongol S., et al. . (2015). Undifferentiated febrile illness in Kathmandu, Nepal. Am. J. Trop. Med. Hyg. 92, 875–878. 10.4269/ajtmh.14-0709
- Thriemer K., Ley B., Menten J., Jacobs J., van den Ende J. (2013). A systematic review and meta-analysis of the performance of two point of care typhoid fever tests, Tubex TF and Typhidot, in endemic countries. PLoS ONE 8:e81263. 10.1371/journal.pone.0081263
- Waddington C. S., Darton T. C., Jones C., Haworth K., Peters A., John T., et al. . (2014). An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution. Clin. Infect. Dis. 58, 1230–1240. 10.1093/cid/ciu078
- Wain J., Diep T. S., Ho V. A., Walsh A. M., Hoa N. T. T., Parry C. M., et al. . (1998). Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J. Clin. Microbiol. 36, 1683–1687.
- Wain J., Hendriksen R. S., Mikoleit M. L., Keddy K. H., Ochiai R. L. (2015). Typhoid fever. Lancet 385, 1136–1145. 10.1016/S0140-6736(13)62708-7
Source: PubMed